Clinical Trial Update: A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer [Phase 3]

View source ↗

Summary

Phase 3 study investigating SHR-1701 with bevacizumab and chemotherapy in advanced or metastatic non-squamous non-small-cell lung cancer; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• SHR-1701

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer | Phase 3 | Status: UNKNOWN